Next Article in Journal
Revealing Metabolic Perturbation Following Heavy Methamphetamine Abuse by Human Hair Metabolomics and Network Analysis
Next Article in Special Issue
Mutational Landscape and Environmental Effects in Bladder Cancer
Previous Article in Journal
There and Back Again: Leptin Actions in White Adipose Tissue
Previous Article in Special Issue
Chemopreventive Agent 3,3′-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells

Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies

School of Science, RMIT University, Melbourne, VIC 3083, Australia
School of Health and Biomedical Sciences, RMIT University, PO Box 71, Melbourne, VIC 3083, Australia
Faculty of Agricultural Science and Engineering, University of Tehran, Karaj 31587, Iran
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(17), 6040;
Received: 30 July 2020 / Revised: 17 August 2020 / Accepted: 18 August 2020 / Published: 21 August 2020
(This article belongs to the Special Issue The Effect of Dietary Factors on Cancer 2.0)
Melanoma is the fourth most common type of cancer diagnosed in Australians after breast, prostate, and colorectal cancers. While there has been substantial progress in the treatment of cancer in general, malignant melanoma, in particular, is resistant to existing medical therapies requiring an urgent need to develop effective treatments with lesser side effects. Several studies have shown that “cannabinoids”, the major compounds of the Cannabis sativaL. plant, can reduce cell proliferation and induce apoptosis in melanoma cells. Despite prohibited use of Cannabis in most parts of the world, in recent years there have been renewed interests in exploiting the beneficial health effects of the Cannabis plant-derived compounds. Therefore, the aim of this study was in the first instance to review the evidence from in vivo studies on the effects of cannabinoids on melanoma. Systematic searches were carried out in PubMed, Embase, Scopus, and ProQuest Central databases for relevant articles published from inception. From a total of 622 potential studies, six in vivo studies assessing the use of cannabinoids for treatment of melanoma were deemed eligible for the final analysis. The findings revealed cannabinoids, individually or combined, reduced tumor growth and promoted apoptosis and autophagy in melanoma cells. Further preclinical and animal studies are required to determine the underlying mechanisms of cannabinoids-mediated inhibition of cancer-signaling pathways. Well-structured, randomized clinical studies on cannabinoid use in melanoma patients would also be required prior to cannabinoids becoming a viable and recognized therapeutic option for melanoma treatment in patients. View Full-Text
Keywords: medicinal herbs; apoptosis; THC; CBD; melanoma; cannabinoids medicinal herbs; apoptosis; THC; CBD; melanoma; cannabinoids
Show Figures

Figure 1

MDPI and ACS Style

Bachari, A.; Piva, T.J.; Salami, S.A.; Jamshidi, N.; Mantri, N. Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies. Int. J. Mol. Sci. 2020, 21, 6040.

AMA Style

Bachari A, Piva TJ, Salami SA, Jamshidi N, Mantri N. Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies. International Journal of Molecular Sciences. 2020; 21(17):6040.

Chicago/Turabian Style

Bachari, Ava, Terrence J. Piva, Seyed A. Salami, Negar Jamshidi, and Nitin Mantri. 2020. "Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies" International Journal of Molecular Sciences 21, no. 17: 6040.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop